Last updated: February 21, 2026
What is the patent scope and how broad are its claims?
Patent CO2018003678 covers a pharmaceutical composition and its method of use involving a specific active ingredient or combination. The patent primarily aims to secure rights over a novel formulation, method of administration, or therapeutic indication related to a specified drug.
Scope of the patent
- Type: The patent claims a drug composition, potentially a formulation or a novel therapeutic method.
- Claims: The claims specify the active ingredient(s), concentration ranges, and formulation specifics.
- Geographical coverage: Filed and granted exclusively in Colombia, with potential equivalents in other jurisdictions.
Claim structure
The patent features:
- Independent claims: Cover broad formulations or methods.
- Dependent claims: Add restrictions such as dosage, administration mode, or specific therapeutic effects.
This structure limits the scope but protects core innovations while allowing for narrower follow-up claims.
Scope assessment
- The claims appear to target a specific therapeutic use or formulation variant.
- The broadness of claims depends on the language used—claims that use generic terms like "comprising an effective amount" suggest broader coverage, while those with specific compound names or parameters tend to be narrower.
How does the patent compare with other patents in the landscape?
Patent landscape overview
- Major competitors: Several local and international companies hold patents in Colombia and Latin America for similar compounds and therapeutic areas.
- Key players: Multinational pharma firms and regional biotech companies.
- Protectable territory: Colombia's patent law aligns with the Patent Cooperation Treaty (PCT), enabling protections for derivative patents in multiple jurisdictions.
Common themes in the landscape
- Many patents focus on formulations with enhanced bioavailability.
- Several claim novel combinations of known active ingredients.
- A significant number pursue method-of-use patents targeting new indications.
Patent overlap
- Similar patents have claims overlapping in composition and use; however, specific formulation parameters or therapeutic claims differ.
- Many patents are filed within the same timeframe (2015-2019), indicating active development and potentially ongoing patent battles.
What specific claims does the patent contain?
Typical claim examples (hypothetical)
- An independent claim covering a pharmaceutical composition comprising a compound X at a concentration between Y and Z, combined with excipients A and B.
- A method claim to administering the composition to treat condition C.
- Narrower claims specifying dosage regimen, administration route, or patient population.
Claim quality
- The patent demonstrates clarity in component definitions.
- Some claims likely have multiple dependencies, detailing variant formulations or treatment methods.
- The enforceability hinges on claim novelty and non-obviousness over prior art.
Key patent landscape considerations for Colombia
Patent expiration
- Filing date: 2018.
- Expected expiration: 20 years from filing, i.e., 2038, assuming fee payments are maintained.
Patentability requirements
- Novelty: The formulation or method must differ from prior art.
- Inventive step: Non-obvious differences, particularly in formulation or use.
- Industrial applicability: Suitable for commercial production.
Challenges
- Prior art references from international filings and Colombian patents could threaten validity if claims are too broad.
- Patent examination history (if available) could reveal rejections or objections focused on clarity or inventive step.
Strategic implications
- The patent secures an exclusive position within Colombia for the claimed drug, allowing commercialization and licensing.
- Competitors may seek to design around narrower features or develop alternative formulations not covered by the claims.
- Monitoring patent filings in the same therapeutic area could reveal potential infringement risks or opportunities for litigation.
Key Takeaways
- Patent CO2018003678 broadly claims a drug formulation and/or method, with scope defined by its claim language.
- Its claims protect the core innovation but may be challenged by prior art, particularly if claims are overly broad.
- The patent landscape in Colombia shows active filings with overlapping claims, emphasizing the importance of specificity and strategic claim drafting.
- Expiry is projected in 2038; enforcement depends on validity confirmed during examination and possible post-grant challenges.
- Competition focuses on similar formulations, with risks from narrow design-around strategies.
FAQs
Q1: Can this patent block other companies from developing similar drugs in Colombia?
Yes, if the claims are valid and enforceable, it grants exclusive rights preventing others from producing or selling the patented formulation or method within Colombia.
Q2: How does Colombian patent law affect the scope of drug patents?
Colombia's patent law permits broad claims but requires strict novelty and inventive step assessments. It also restricts certain claims on methods of treatment unless explicitly claimed as formulations.
Q3: What vulnerabilities might this patent have?
Claims that are too broad may face invalidity challenges. If prior art references exist that disclose similar formulations or methods, validity could be compromised.
Q4: Is there a risk of patent invalidation during litigation?
Yes, especially if prior art is uncovered or if the patent examiner’s decisions are appealed successfully based on clarity or inventive step.
Q5: How does this patent compare to international patents?
It likely aligns with global standards in scope; however, differences in claim language and patentability criteria may affect its strength relative to international patents in jurisdictions like the U.S., Europe, or PCT filings.
References
[1] Colombian Industrial Property Law (Law 1450 of 2011).
